These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16217698)

  • 1. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
    Arendt G
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
    Silva MT; Araújo A
    J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological complications of HIV infection. Review: new diagnostic, therapeutic and prognostic aspects].
    Radziwill AJ; Kappos L; Battegay M; Steck AJ
    Schweiz Med Wochenschr; 2000 Apr; 130(13):457-70. PubMed ID: 10812641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis].
    Arendt G; Haslinger BA
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():66-9. PubMed ID: 15011596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuro-AIDS in the cART era].
    Arendt G; Nolting T
    Fortschr Neurol Psychiatr; 2012 Aug; 80(8):450-7. PubMed ID: 22895840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological manifestations of the HIV infection].
    Arendt G; Nolting T
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():75-7. PubMed ID: 16385884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system disorders in AIDS.
    Levy RM; Bredesen DE; Rosenblum ML; Davis RL
    Immunol Ser; 1989; 44():371-401. PubMed ID: 2489119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focal presentation of progressive multifocal leukoencephalopathy: first manifestation of human immunodeficiency virus infection].
    Martínez L; Cuesta J; Santos S; Tejero C
    Neurologia; 2008 Oct; 23(8):532-5. PubMed ID: 18392989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the neuropathology of HIV in the HAART era.
    Bell JE
    Histopathology; 2004 Dec; 45(6):549-59. PubMed ID: 15569045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.
    Moroni M; Antinori S
    AIDS; 2003 Apr; 17 Suppl 1():S51-64. PubMed ID: 12870531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and dementia in older adults.
    Valcour V; Paul R
    Clin Infect Dis; 2006 May; 42(10):1449-54. PubMed ID: 16619159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological disease in patients with human immunodeficiency virus infection.
    Gane EJ; Ellis-Pegler RB; Thomas MG
    N Z Med J; 1992 Feb; 105(928):49-51. PubMed ID: 1542470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab.
    Lima MA; Koralnik IJ
    J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.